The Gene Study

Study Objective:

• The study is exploring the potential benefit of pairing the study medication with an already approved and available medication (Rabeprazole) and aims to provide a new therapeutic option for severe neurological conditions that currently have limited treatment option's
• This combined therapy approach is hoped it can become a potential treatment for GRIN-related disorders, which include neurodevelopmental conditions like epilepsy, autism, intellectual disability, and behavioral disorders.

Importance of Treatment:

• Developing treatments that can prevent the body's immune system from attacking itself (one way or another) is crucial for improving the lives of millions affected globally.

Clinical Trial Details:

• An independent ethics committee has approved this clinical trial.
• Participants will be reimbursed for their time
  

Call us on 1800 243 733 to discuss your eligibility today!